CIK 0000818033 · Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 942875566
- Phone
- 8582514400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-30 | Collard Craig A Chief Executive Officer | Option exercise | +50,021 | 757,885 | ||
| 2026-04-30 | Collard Craig A Chief Executive Officer | Option exercise · Restricted Stock Units | −34,789 | 382,675 | ||
| 2026-04-30 | Collard Craig A Chief Executive Officer | Option exercise · Restricted Stock Units | −50,021 | 750,316 | ||
| 2026-04-19 | Forbes William P EVP, Chief Development Officer | Option exercise | +3,874 | 185,647 | ||
| 2026-04-19 | Forbes William P EVP, Chief Development Officer | Option exercise · Restricted Stock Units | −3,874 | 27,120 | ||
| 2026-04-19 | Collard Craig A Chief Executive Officer | Option exercise | +13,797 | 662,052 | ||
| 2026-04-19 | Collard Craig A Chief Executive Officer | Option exercise · Restricted Stock Units | −13,797 | 96,758 | ||
| 2026-04-19 | Duarte Ira EVP, Chief Financial Officer | Option exercise | +3,874 | 215,876 | ||
| 2026-04-19 | Duarte Ira EVP, Chief Financial Officer | Option exercise · Restricted Stock Units | −3,874 | 27,120 | ||
| 2026-04-03 | Collard Craig A Chief Executive Officer | Option exercise | +62,500 | 648,255 | ||
| 2026-04-03 | Collard Craig A Chief Executive Officer | Option exercise · Restricted Stock Units | −62,500 | 62,500 | ||
| 2026-01-31 | Duarte Ira EVP, Chief Financial Officer | Option exercise | +11,695 | 195,356 | ||
| 2026-01-31 | Duarte Ira EVP, Chief Financial Officer | Option exercise · Restricted Stock Units | −11,695 | 140,332 | ||
| 2026-01-31 | Forbes William P EVP, Chief Development Officer | Option exercise | +11,695 | 181,773 | ||
| 2026-01-31 | Forbes William P EVP, Chief Development Officer | Option exercise · Restricted Stock Units | −11,695 | 140,332 | ||
| 2026-01-31 | Collard Craig A Chief Executive Officer | Option exercise | +34,789 | 571,710 | ||
| 2026-01-31 | Collard Craig A Chief Executive Officer | Option exercise · Restricted Stock Units | −34,789 | 417,464 | ||
| 2026-01-30 | Collard Craig A Chief Executive Officer | Grant or award · Restricted Stock Units | +800,337 | 800,337 | ||
| 2026-01-30 | Collard Craig A Chief Executive Officer | Grant or award · Performance Stock Units | +800,336 | 800,336 | ||
| 2026-01-30 | Christian Waage Director | Grant or award | +53,960 | 53,960 |
Page 5 of 28 · 557 trades